Right ventricular failure adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 6,954 adverse event reports that record the MedDRA preferred term Right ventricular failure. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 236 reports in the 12 months to June 2026 and 224 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 1,294 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 236 (under 0.1%) record this term. Reports for female patients were 61.8% of the reports that record this term and 52.7% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 112 drug pages with 10 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Right ventricular failure name as a suspect product, in order of name
Drug	Class	Reports with this term
Acenocoumarol		18
Acetaminophen		11
Adalimumab	Tumor necrosis factor blocker	12
Adcirca	Phosphodiesterase 5 inhibitor	162
Adempas	Soluble guanylate cyclase stimulator	210
Alvesco		10
Ambrisentan	Endothelin receptor antagonist	599
Amiodarone hcl		10
Amitriptyline		22
Apixaban	Factor Xa inhibitor	18
Aspirin	Nonsteroidal anti-inflammatory drug	34
Atorvastatin		14
Avandia		49
Azathioprine	Purine antimetabolite	22
Bactrim DS	Dihydrofolate reductase inhibitor antibacterial	10
Bortezomib	Proteasome inhibitor	18
Bosentan	Endothelin receptor antagonist	130
Busulfan	Alkylating drug	31
Carboplatin	Platinum-based drug	19
Carfilzomib	Proteasome inhibitor	10
Carvedilol	alpha-Adrenergic blocker	14
Colchicine	Alkaloid	17
Coumadin		24
Cyclophosphamide	Alkylating drug	86
Cyclosporine	Calcineurin inhibitor immunosuppressant	27
Cytarabine	Nucleoside metabolic inhibitor	17
Dasatinib	Kinase inhibitor	11
Dexamethasone	Corticosteroid	47
Digoxin	Cardiac glycoside	64
Doxorubicin	Anthracycline topoisomerase inhibitor	17
Eliquis	Factor Xa inhibitor	12
Enbrel	Tumor necrosis factor blocker	17
Entresto	Angiotensin 2 receptor blocker	24
Epinephrine	Catecholamine	11
Epoprostenol	Prostacycline vasodilator	75
Epoprostenol Act		22
Epoprostenol sodium		113
Etoposide	Topoisomerase inhibitor	18
Flolan		118
Fluorouracil	Nucleoside metabolic inhibitor	20
Folic acid		10
Fulvestrant	Estrogen receptor antagonist	11
Furosemide	Loop diuretic	87
Glipizide	Sulfonylurea	13
Heparin		29
Humira		24
Iloprost		33
Imatinib	Kinase inhibitor	41
Influenza virus vaccine		14
Insulin	Insulin analog	14
Keytruda	Programmed death Receptor-1 blocking antibody	12
Kisqali	Kinase inhibitor	10
Lasix	Loop diuretic	44
Lenalidomide	Thalidomide analog	10
Letairis	Endothelin receptor antagonist	315
Lisinopril	Angiotensin converting enzyme inhibitor	13
Lovastatin	HMG-CoA reductase inhibitor	16
Macitentan	Endothelin receptor antagonist	121
Melphalan	Alkylating drug	12
Metformin	Biguanide	18
Methotrexate	Folate analog metabolic inhibitor	39
Methylprednisolone	Corticosteroid	15
Mycophenolate mofetil	Antimetabolite immunosuppressant	39
Nitric oxide	Vasodilator	17
Nuvaring	Estrogen	15
Ofev	Kinase inhibitor	29
Opsumit	Endothelin receptor antagonist	860
Orenitram	Prostacycline vasodilator	144
Oxaliplatin	Platinum-based drug	11
Paclitaxel	Microtubule inhibitor	10
Pantoprazole	Proton pump inhibitor	11
Pantoprazole sodium	Proton pump inhibitor	10
Paracetamol		10
Pradaxa	Direct thrombin inhibitor	17
Prednisolone	Corticosteroid	43
Prednisone	Corticosteroid	42
Remodulin	Prostacycline vasodilator	822
Revatio	Phosphodiesterase 5 inhibitor	133
Revlimid	Thalidomide analog	18
Ribavirin	Nucleoside analog antiviral	10
Riociguat	Soluble guanylate cyclase stimulator	26
Rituximab	CD20-directed cytolytic antibody	61
Rivaroxaban	Factor Xa inhibitor	11
Selexipag	Prostacyclin receptor agonist	47
Seroquel	Atypical antipsychotic	10
Sildenafil	Phosphodiesterase 5 inhibitor	190
Sildenafil citrate	Phosphodiesterase 5 inhibitor	87
Simvastatin	HMG-CoA reductase inhibitor	12
Sotatercept		10
Spironolactone	Aldosterone antagonist	60
Symbicort	Corticosteroid	11
Tacrolimus	Calcineurin inhibitor immunosuppressant	34
Tadalafil	Phosphodiesterase 5 inhibitor	121
Terazosin	alpha-Adrenergic blocker	12
Tracleer	Endothelin receptor antagonist	809
Trastuzumab	HER2/neu receptor antagonist	20
Treprostinil	Prostacycline vasodilator	88
Treprostinil sodium		21
Tyvaso	Prostacycline vasodilator	252
Tyvaso DPI	Prostacycline vasodilator	29
Uptravi	Prostacyclin receptor agonist	466
Velcade	Proteasome inhibitor	13
Veletri	Prostacycline vasodilator	391
Ventavis		170
Vincristine		15
Vioxx		15
Volibris		10
Warfarin	Vitamin K antagonist	34
Warfarin sodium	Vitamin K antagonist	10
Winrevair		17
Xarelto	Factor Xa inhibitor	50
Zoledronic acid	Bisphosphonate	10

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 57 pharmacologic classes with 10 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Right ventricular failure name, in order of name
Class	Reports with this term
Aldosterone antagonist	70
Alkaloid	17
Alkylating drug	141
alpha-Adrenergic blocker	28
Angiotensin 2 receptor blocker	44
Angiotensin converting enzyme inhibitor	28
Anthracycline topoisomerase inhibitor	24
Anti-coagulant	17
Anti-epileptic agent	17
Antimetabolite immunosuppressant	48
Aromatase inhibitor	11
Atypical antipsychotic	18
Benzodiazepine	13
beta-Adrenergic blocker	17
Biguanide	23
Bisphosphonate	16
Calcineurin inhibitor immunosuppressant	70
Cardiac glycoside	64
Catecholamine	19
CD20-directed cytolytic antibody	64
Corticosteroid	164
Dihydrofolate reductase inhibitor antibacterial	10
Direct thrombin inhibitor	17
Endothelin receptor antagonist	2,834
Estrogen	17
Estrogen receptor antagonist	11
Factor Xa inhibitor	94
Folate analog metabolic inhibitor	52
HER2/neu receptor antagonist	31
HMG-CoA reductase inhibitor	39
Insulin analog	16
Interleukin-6 receptor antagonist	14
Kinase inhibitor	141
Loop diuretic	147
Microtubule inhibitor	22
Nonsteroidal anti-inflammatory drug	64
Nucleoside analog antiviral	10
Nucleoside metabolic inhibitor	57
Opioid agonist	38
Phosphodiesterase 5 inhibitor	701
Platinum-based drug	36
Programmed death Receptor-1 blocking antibody	24
Prostacyclin receptor agonist	513
Prostacycline vasodilator	1,801
Proteasome inhibitor	50
Proton pump inhibitor	42
Purine antimetabolite	22
Serotonin reuptake inhibitor	15
Soluble guanylate cyclase stimulator	236
Sulfonylurea	13
Thalidomide analog	33
Topoisomerase inhibitor	18
Tumor necrosis factor blocker	38
Vascular endothelial growth factor inhibitor	13
Vasodilator	19
Vitamin K antagonist	44
Xanthine oxidase inhibitor	11

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Right ventricular failure, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Right ventricular failure
Age	Reports	Share
Under 2	52	0.7%
2 to 11	69	1%
12 to 17	96	1.4%
18 to 44	1,104	15.9%
45 to 64	1,922	27.6%
65 to 74	1,291	18.6%
75 and over	936	13.5%
Age not given	1,484	21.3%

Sex of the patient in the reports that record Right ventricular failure
Sex	Reports	Share
Female	4,296	61.8%
Male	2,240	32.2%
Unknown or not given	418	6%

Age and sex are as the report gives them. 55.5% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Right ventricular failure: adverse event reports that record this term. https://reportedreactions.com/reaction/right-ventricular-failure/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Right ventricular failure mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page